Hear’s the content from the provided web search results:
- Duke Health – WATCHMAN Device for Left Atrial Appendage Closure
– AFib increases stroke risk by five times.
– AFib prevents full contraction of the heart’s atria, causing blood to pool in the left atrial appendage, forming clots.
– The WATCHMAN device closes off the left atrial appendage to prevent clots and reduce stroke risk.
– URL: Duke health
- Chicago Cardiology – Minimally Invasive Watchman Surgery for Stroke Risk Reduction
– Benefits of the Watchman implant frequently enough outweigh procedural risks.
– The device is a permanent implant with no maintenance or follow-up care.
– Benefits include stroke risk reduction.
– URL: Chicago Cardiology
- Watchman – Why Choose WATCHMAN – one-time Implant
– The Watchman device reduces bleeding risks associated with long-term blood thinners.
– It’s a one-time implant with a short procedure time (around 30 minutes) and same-day discharge.
– University Hospitals has a success rate of over 99% and performs one of the highest volumes of these procedures worldwide.- only about 50% of prescribed blood thinner patients take them due to cost, side effects, or noncompliance.
– The Watchman addresses stroke risk in AFib patients, particularly those at additional risk like diabetics.
– URL: Watchman
Expert Insights on WATCHMAN Device for Atrial Fibrillation Stroke Risk Reduction
Atrial Fibrillation (AFib) is a common heart rhythm condition that drastically increases the risk of stroke. In recent years, the WATCHMAN device has emerged as a promising solution to reduce this risk by closing off the left atrial appendage. Our senior editor from world-today-news.com sat down with cardiac specialist Dr. Emily Johnson,an expert on the WATCHMAN procedure,to discuss its benefits,risks,and patient outcomes.
Understanding the Connection Between AFib and Stroke
World-Today-News.com Editor: Thank you for joining us, Dr. johnson.Can you first explain how AFib increases the risk of stroke?
Dr.Emily Johnson: AFib disrupts the normal contractile function of the heart’s atria, leading to blood pooling in the left atrial appendage. This pooling can cause blood clots to form, which can then travel to the brain, leading to a stroke. In patients with AFib, this risk is increased by up to five times.
The Role of WATCHMAN in Stroke Risk Reduction
Editor: How does the WATCHMAN device address this issue?
Dr. Johnson: The WATCHMAN device is designed to close off the left atrial appendage where these clots commonly form. By closing off this area, the device prevents clots from escaping into the bloodstream, thereby reducing the risk of a stroke.
Benefits and Risks of the WATCHMAN Procedure
Editor: What are the primary benefits and risks associated with this procedure?
Dr. Johnson: The primary benefit is a significant reduction in the risk of stroke. Another major advantage is that it eliminates the need for long-term blood thinner medication, thereby reducing bleeding risks. the procedure itself is minimally invasive, frequently enough lasting around 30 minutes, and patients can be discharged the same day.
However, like any medical procedure, there are risks. These include potential complications during the implant, and also long-term risks like device-related thrombosis. But generally, the benefits outweigh the risks for many patients.
The Success Rate and Patient Outcomes
Editor: can you discuss the success rate of the WATCHMAN procedure?
Dr. Johnson: The procedure has shown remarkable success.Many institutions report success rates of over 99%. University Hospitals, as an example, has one of the highest volumes of these procedures globally and boasts an exceptionally high success rate.
Adherence to Blood Thinners
Editor: Why is adherence to blood thinners an issue, and how does the WATCHMAN device help?
Dr. Johnson: Adherence to blood thinners can be a challenge due to factors like cost, side effects, and patient noncompliance. Only about 50% of prescribed blood thinner patients consistently take them. The WATCHMAN device addresses this by providing an option solution that reduces stroke risk without the need for blood thinners.
Recommendations for AFib Patients
Editor: Who would you recommend the WATCHMAN device to?
Dr. Johnson: It’s particularly beneficial for patients who are at a higher risk of stroke due to AFib and are unable or unwilling to take long-term blood thinners. This includes individuals like diabetics and those with a history of bleeding complications on blood thinners.
Summary and Conclusion
editor: what are the main takeaways regarding the WATCHMAN device for stroke risk reduction in AFib patients?
Dr. Johnson: The WATCHMAN device is an effective and safe option for reducing stroke risk in AFib patients, especially for those who can’t take blood thinners. With high success rates and the advantage of a one-time implant, it provides significant benefits while minimizing long-term risks.
Thank you, Dr. Johnson, for sharing your expertise on this crucial topic.
Learn more about WATCHMAN at Duke Health
Discover the benefits of WATCHMAN at Chicago Cardiology
Why Choose the WATCHMAN Device
